Ya-Ju Du

471 total citations
13 papers, 366 citations indexed

About

Ya-Ju Du is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ya-Ju Du has authored 13 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Ya-Ju Du's work include Genetic factors in colorectal cancer (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ya-Ju Du is often cited by papers focused on Genetic factors in colorectal cancer (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ya-Ju Du collaborates with scholars based in China and United States. Ya-Ju Du's co-authors include Bing-Rong Liu, Ji-Tao Song, Xinhong Wang, Wei Xu, Jing Chen, Aiyun Liu, Jing Chen, Jing Chen, Hao Li and Ying Hu and has published in prestigious journals such as Experimental Biology and Medicine, Surgical Endoscopy and Cancer Biology & Therapy.

In The Last Decade

Ya-Ju Du

13 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ya-Ju Du China 10 125 112 104 70 66 13 366
Hong-Chuan Zhao China 9 118 0.9× 71 0.6× 39 0.4× 31 0.4× 96 1.5× 14 301
Shiann Pan Taiwan 11 122 1.0× 99 0.9× 37 0.4× 50 0.7× 31 0.5× 25 309
Hideo Tomioka Japan 11 131 1.0× 72 0.6× 86 0.8× 17 0.2× 31 0.5× 27 322
Hikota Hayashi Japan 11 76 0.6× 164 1.5× 126 1.2× 18 0.3× 44 0.7× 25 421
Hiromichi Yamai Japan 10 106 0.8× 188 1.7× 125 1.2× 18 0.3× 22 0.3× 34 410
Han-Chieh Lin Taiwan 12 121 1.0× 79 0.7× 55 0.5× 18 0.3× 83 1.3× 24 344
Liangying Ye China 6 263 2.1× 41 0.4× 75 0.7× 33 0.5× 73 1.1× 9 409
Zhe‐Ming Zhao China 11 130 1.0× 85 0.8× 86 0.8× 18 0.3× 23 0.3× 23 347
H. Suetsugu Japan 6 203 1.6× 111 1.0× 20 0.2× 56 0.8× 46 0.7× 7 389
Mengli Gu China 10 153 1.2× 57 0.5× 45 0.4× 30 0.4× 43 0.7× 18 311

Countries citing papers authored by Ya-Ju Du

Since Specialization
Citations

This map shows the geographic impact of Ya-Ju Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya-Ju Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya-Ju Du more than expected).

Fields of papers citing papers by Ya-Ju Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya-Ju Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya-Ju Du. The network helps show where Ya-Ju Du may publish in the future.

Co-authorship network of co-authors of Ya-Ju Du

This figure shows the co-authorship network connecting the top 25 collaborators of Ya-Ju Du. A scholar is included among the top collaborators of Ya-Ju Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya-Ju Du. Ya-Ju Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Liu, Aiyun, et al.. (2018). Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice. Microbial Pathogenesis. 125. 418–422. 42 indexed citations
3.
Li, Hao, et al.. (2017). Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice. Molecular Medicine Reports. 15(5). 2604–2610. 27 indexed citations
4.
Liu, Mingna, et al.. (2015). Functional mechanism of the enhancement of 5-fluorouracil sensitivity by TUSC4 in colon cancer cells. Oncology Letters. 10(6). 3682–3688. 14 indexed citations
5.
Liu, Aiyun, Ya-Ju Du, Guang Yang, et al.. (2014). Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer. Cancer Biology & Therapy. 15(5). 489–495. 13 indexed citations
6.
Liu, Bing-Rong, et al.. (2014). Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma. Oncology Letters. 7(4). 1175–1178. 84 indexed citations
7.
Chen, Jing, Ya-Ju Du, Hangyu Wang, et al.. (2014). Endostar, a novel human recombinant endostatin, attenuates liver fibrosis in CCl4-induced mice. Experimental Biology and Medicine. 239(8). 998–1006. 20 indexed citations
8.
Liu, Dan, et al.. (2013). Association of body mass index and smoking on outcome of Chinese patients with colorectal cancer. World Journal of Surgical Oncology. 11(1). 271–271. 13 indexed citations
9.
Liu, Bing-Rong, et al.. (2013). Tunneling endoscopic muscularis dissection for subepithelial tumors originating from the muscularis propria of the esophagus and gastric cardia. Surgical Endoscopy. 27(11). 4354–4359. 72 indexed citations
10.
Liu, Mingna, et al.. (2012). Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells. Molecular Medicine Reports. 12(1). 1189–1196. 4 indexed citations
11.
Wei, Guochao, Jing Chen, Aiyun Liu, et al.. (2012). Prevalence of Helicobacter pylori vacA, cagA and iceA genotypes and correlation with clinical outcome. Experimental and Therapeutic Medicine. 4(6). 1039–1044. 26 indexed citations
12.
Du, Ya-Ju. (2011). Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats. Molecular Medicine Reports. 4(5). 811–6. 36 indexed citations
13.
Li, Baojie, et al.. (2006). BRAF, K-ras and BAT26 mutations in colorectal polyps and stool.. PubMed. 12(32). 5148–52. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026